Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jutta Blank

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Medicinal Chemistry|September 15, 2020
Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4Robin A Fairhurst, Thomas Knoepfel, Nicole Buschmann, et al.
Nature|April 24, 2024
Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancersStephane Ferretti, Jacques Hamon, Ruben de Kanter, et al.
Nature Chemical Biology|January 19, 2021
BET bromodomain inhibitors regulate keratinocyte plasticityGabi Schutzius, Christian Kolter, Sebastian Bergling, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Medicinal Chemistry|September 15, 2020
Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4Robin A Fairhurst, Thomas Knoepfel, Nicole Buschmann, et al.
Nature|April 24, 2024
Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancersStephane Ferretti, Jacques Hamon, Ruben de Kanter, et al.
Nature Chemical Biology|January 19, 2021
BET bromodomain inhibitors regulate keratinocyte plasticityGabi Schutzius, Christian Kolter, Sebastian Bergling, et al.
Pageof 3